The University of Chicago Header Logo

Connection

Michael Davidson to Hematinics

Back to Details
This is a "connection" page, showing publications Michael Davidson has written about Hematinics.
Michael Davidson
Connection Strength
0.170
Hematinics
  1. Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. J Am Soc Nephrol. 2021 01; 32(1):211-222.
    View in: PubMed
    Score: 0.170
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.